These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35963766)

  • 1. Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.
    Hamilton M; Gnjidic D; Christine Lin CW; Jansen J; Weir KR; Shaheed CA; Blyth F; Mathieson S
    Res Social Adm Pharm; 2022 Dec; 18(12):4083-4091. PubMed ID: 35963766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
    Hamilton M; Mathieson S; Gnjidic D; Jansen J; Weir K; Shaheed CA; Blyth F; Lin CC
    Pain; 2022 Apr; 163(4):e518-e526. PubMed ID: 33990105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Bourne A; Maher C; Mathieson S; Lin CC; O'Connor DA
    BMJ Open; 2019 Nov; 9(11):e034039. PubMed ID: 31722956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials.
    Mathieson S; Maher CG; Ferreira GE; Hamilton M; Jansen J; McLachlan AJ; Underwood M; Lin CC
    Drugs; 2020 Oct; 80(15):1563-1576. PubMed ID: 32737739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines.
    Langford AV; Gnjidic D; Lin CC; Bero L; Blyth F; Penm J; Schneider CR
    Pain; 2021 Nov; 162(11):2686-2692. PubMed ID: 33769364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.
    Goyal P; Requijo T; Siceloff B; Shen MJ; Masterson Creber R; Hilmer SN; Kronish IM; Lachs MS; Safford MM
    Drugs Aging; 2020 Feb; 37(2):125-135. PubMed ID: 31858449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults.
    Niznik JD; Ferreri SP; Armistead LT; Kelley CJ; Schlusser C; Hughes T; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2022 Sep; 39(9):739-748. PubMed ID: 35896779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
    Margraf AM; Davoodi NM; Chen K; Shield RR; McAuliffe LM; Collins CM; Zullo AR
    Am J Health Syst Pharm; 2023 Jan; 80(2):53-60. PubMed ID: 36205419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and Physician Perspectives of Deprescribing Potentially Inappropriate Medications in Older Adults with a History of Falls: a Qualitative Study.
    Hahn EE; Munoz-Plaza CE; Lee EA; Luong TQ; Mittman BS; Kanter MH; Singh H; Danforth KN
    J Gen Intern Med; 2021 Oct; 36(10):3015-3022. PubMed ID: 33469744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing long-term opioid therapy in patients with chronic pain.
    Glare P; Ashton-James C; Han E; Nicholas M
    Intern Med J; 2020 Oct; 50(10):1185-1191. PubMed ID: 33111411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines.
    Hamilton M; Kwok WS; Hsu A; Mathieson S; Gnjidic D; Deyo R; Ballantyne J; Von Korff M; Blyth F; Lin CC
    Pain; 2023 Mar; 164(3):485-493. PubMed ID: 36001299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S.
    Gruß I; Firemark A; Mayhew M; McMullen CK; DeBar LL
    Int J Drug Policy; 2019 Dec; 74():62-68. PubMed ID: 31536957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial.
    Turner JP; Caetano P; Tannenbaum C
    Trials; 2019 Jul; 20(1):412. PubMed ID: 31288859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study.
    Lee S; Bobb Swanson M; Fillman A; Carnahan RM; Seaman AT; Reisinger HS
    J Am Geriatr Soc; 2023 Jan; 71(1):62-76. PubMed ID: 36258309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines.
    Hawkins EJ; Lott AM; Danner AN; Malte CA; Hagedorn HJ; Berger D; Donovan LM; Sayre GG; Mariano AJ; Saxon AJ
    Pain Med; 2021 Jul; 22(7):1559-1569. PubMed ID: 33661287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.